Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles

Abstract

Our study suggests that optimized DNR-MNPs formulation possesses sustained drug-release and favorable antitumor properties, which may be used as a conventional dosage form for antitumor therapy.